» Articles » PMID: 6447156

Increased Permeability of the Glomerular Basement Membrane to Ferritin After Removal of Glycosaminoglycans (heparan Sulfate) by Enzyme Digestion

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 1980 Aug 1
PMID 6447156
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Glomerular basement membranes (GBM's) were subjected to digestion in situ with glycosaminoglycan-degrading enzymes to assess the effect of removing glycosaminoglycans (GAG) on the permeability of the GBM to native ferritin (NF). Kidneys were digested by perfusion with enzyme solutions followed by perfusion with NF. In controls treated with buffer alone, NF was seen in high concentration in the capillary lumina, but the tracer did not penetrate to any extent beyond the lamina rara interna (LRI) of the GBM, and litte or no NF reached the urinary spaces. Findings in kidneys perfused with Streptomyces hyaluronidase (removes hyaluronic acid) and chondroitinase-ABC (removes hyaluronic acid, chondroitin 4- and 6-sulfates, and dermatan sulfate, but not heparan sulfate) were the same as in controls. In kidneys digested with heparinase (which removes most GAG including heparan sulfate), NF penetrated the GBM in large amounts and reached the urinary spaces. Increased numbers of tracer molecules were found in the lamina densa (LD) and lamina rara externa (LRE) of the GBM. In control kidneys perfused with cationized ferritin (CF), CF bound to heparan-sulfate rich sites demonstrated previously in the laminae rarae; however, no CF binding was seen in heparinase-digested GBM's, confirming that the sites had been removed by the enzyme treatment. The results demonstrated that removal of heparan sulfate (but not other GAG) leads to a dramatic increase in the permeability of the GBM to NF.

Citing Articles

Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations.

Rogers M, Schultz D, Karnaros V, Shepheard S Brain Commun. 2023; 5(6):fcad287.

PMID: 37946793 PMC: 10631861. DOI: 10.1093/braincomms/fcad287.


Small leucine rich proteoglycans: Biology, function and their therapeutic potential in the ocular surface.

Gesteira T, Verma S, Coulson-Thomas V Ocul Surf. 2023; 29:521-536.

PMID: 37355022 PMC: 11092928. DOI: 10.1016/j.jtos.2023.06.013.


VSIG4 interaction with heparan sulfates inhibits VSIG4-complement binding.

Ebstein S, Rafique A, Zhou Y, Krasco A, Montalvo-Ortiz W, Yu L Glycobiology. 2023; 33(7):591-604.

PMID: 37341346 PMC: 10426322. DOI: 10.1093/glycob/cwad050.


Early diabetic kidney disease: Focus on the glycocalyx.

Yu H, Song Y, Li X World J Diabetes. 2023; 14(5):460-480.

PMID: 37273258 PMC: 10236994. DOI: 10.4239/wjd.v14.i5.460.


Spatial composition and turnover of the main molecules in the adult glomerular basement membrane.

Smith D, Azadi A, Lee C, Gardiner B Tissue Barriers. 2022; 11(3):2110798.

PMID: 35959954 PMC: 10364650. DOI: 10.1080/21688370.2022.2110798.


References
1.
Laurent T . In vitro studies on the transport of macromolecules through the connective tissue. Fed Proc. 1966; 25(3):1128-34. View

2.
MOHOS S, Skoza L . Glomerular sialoprotein. Science. 1969; 164(3887):1519-21. DOI: 10.1126/science.164.3887.1519. View

3.
Michael A, Blau E, Vernier R . Glomerular polyanion. Alteration in aminonucleoside nephrosis. Lab Invest. 1970; 23(6):649-57. View

4.
Caulfield J, Farquhar M . The permeability of glomerular capillaries to graded dextrans. Identification of the basement membrane as the primary filtration barrier. J Cell Biol. 1974; 63(3):883-903. PMC: 2109376. DOI: 10.1083/jcb.63.3.883. View

5.
Seiler M, Venkatachalam M, COTRAN R . Glomerular epithelium: structural alterations induced by polycations. Science. 1975; 189(4200):390-3. DOI: 10.1126/science.1145209. View